看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Metrics | Range | Conclusion |
|---|---|---|
| Selected LTM EBIT Multiple | 9.3x - 10.3x | 9.8x |
| Selected Fwd EBIT Multiple | 7.6x - 8.4x | 8.0x |
| Fair Value | $15.49 - $18.52 | $17.01 |
| Upside | 4.7% - 25.2% | 14.9% |
| Benchmarks | Ticker | Full Ticker |
| Amphastar Pharmaceuticals, Inc. | AMPH | NasdaqGS:AMPH |
| Jazz Pharmaceuticals plc | JAZZ | NasdaqGS:JAZZ |
| Intra-Cellular Therapies, Inc. | ITCI | NasdaqGS:ITCI |
| Elite Pharmaceuticals, Inc. | ELTP | OTCPK:ELTP |
| Collegium Pharmaceutical, Inc. | COLL | NasdaqGS:COLL |
| Teva Pharmaceutical Industries Limited | TEVJ.F | OTCPK:TEVJ.F |
| - | - | - |
| Select LTM EBIT Multiple | |||||||
| Benchmark Companies | |||||||
| AMPH | JAZZ | ITCI | ELTP | COLL | TEVJ.F | ||
| NasdaqGS:AMPH | NasdaqGS:JAZZ | NasdaqGS:ITCI | OTCPK:ELTP | NasdaqGS:COLL | OTCPK:TEVJ.F | ||
| Historical EBIT Growth | |||||||
| 5Y CAGR | NM- | 6.1% | NM- | NM- | NM- | 4.4% | |
| 3Y CAGR | 42.0% | 21.9% | NM- | 72.4% | 107.9% | 3.1% | |
| Latest Twelve Months | 2.9% | 6.3% | 26.8% | 74.8% | 4.8% | 6.0% | |
| Historical EBIT Profit Margin | |||||||
| 5 Year Average Margin | 18.1% | 23.1% | -1336.9% | 11.3% | 20.0% | 18.8% | |
| Prior Fiscal Year | 31.0% | 21.1% | -34.3% | 11.6% | 33.6% | 20.1% | |
| Latest Fiscal Year | 28.1% | 21.2% | -17.1% | 19.1% | 31.6% | 20.4% | |
| Latest Twelve Months | 28.1% | 21.2% | -17.1% | 17.4% | 31.6% | 20.4% | |
| Current Trading Multiples | |||||||
| EV / LTM Revenue | 2.46x | 3.60x | 19.15x | 6.76x | 2.78x | 1.97x | |
| EV / LTM EBITDA | 7.0x | 9.6x | -112.2x | 34.3x | 4.8x | 7.3x | |
| EV / LTM EBIT | 8.8x | 17.0x | -111.7x | 38.9x | 8.8x | 9.6x | |
| Low | Mid | High | |||||
| Benchmark EV / LTM EBIT | -111.7x | 8.8x | 38.9x | ||||
| Historical EV / LTM EBIT | 9.6x | 10.8x | 11.8x | ||||
| Selected EV / LTM EBIT | 9.3x | 9.8x | 10.3x | ||||
| (x) LTM EBIT | 3,372 | 3,372 | 3,372 | ||||
| (=) Implied Enterprise Value | 31,380 | 33,032 | 34,683 | ||||
| (-) Non-shareholder Claims * | (15,231) | (15,231) | (15,231) | ||||
| (=) Equity Value | 16,149 | 17,801 | 19,452 | ||||
| (/) Shares Outstanding | 1,145.8 | 1,145.8 | 1,145.8 | ||||
| Implied Value Range | 14.09 | 15.54 | 16.98 | ||||
| FX Rate: USD/USD | 1.0 | 1.0 | 1.0 | Market Price | |||
| Implied Value Range (Trading Cur) | 14.09 | 15.54 | 16.98 | 14.80 | |||
| Upside / (Downside) | -4.8% | 5.0% | 14.7% | ||||
| Equity Waterfall | |||||||
| Benchmark Companies | |||||||
| (in millions) | AMPH | JAZZ | ITCI | ELTP | COLL | TEVJ.F | |
| Enterprise Value | 1,773 | 14,606 | 13,031 | 473 | 1,753 | 32,189 | |
| (+) Cash & Short Term Investments | 222 | 2,994 | 1,001 | 8 | 163 | 3,300 | |
| (+) Investments & Other | 11 | 4 | 0 | 0 | 0 | 0 | |
| (-) Debt | (651) | (6,167) | (17) | (11) | (980) | (18,184) | |
| (-) Other Liabilities | 0 | 0 | 0 | 0 | 0 | (347) | |
| (-) Preferred Stock | 0 | 0 | 0 | 0 | 0 | 0 | |
| (-) Other | 0 | 0 | 0 | 0 | 0 | 0 | |
| Value of Common Equity | 1,355 | 11,437 | 14,015 | 470 | 935 | 16,958 | |
| (/) Shares Outstanding | 47.7 | 93.0 | 106.3 | 1,068.3 | 31.5 | 1,145.8 | |
| Implied Stock Price | 28.43 | 122.92 | 131.81 | 0.44 | 29.71 | 14.80 | |
| FX Conversion Rate to Trading Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |
| Implied Stock Price (Trading Cur) | 28.43 | 122.92 | 131.81 | 0.44 | 29.71 | 14.80 | |
| Trading Currency | USD | USD | USD | USD | USD | USD | |
| FX Rate to Reporting Currency | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 | |